Search - tctmd.com

Displaying 121 - 140 of 185

Sort: Relevancy | Date

Presentation TVT 2022

What (Else) Have We Learned From REDUCE-LAP II?

Presenter: Sanjiv Shah

June 10, 2022

Presentation TVT 2022

Overview of the Interatrial Shunt Device Landscape: Conceptual Basis and Devices

Presenter: Daniel Burkhoff

June 10, 2022

Presentation TVT 2022

The Alleviant No-Implant Interatrial Shunt for HF: The ALLEVIATE HF1 Trial Results

Presenter: Peter S. Fail

June 10, 2022

Presentation THT 2022

Interatrial Shunting in Chronic Heart Failure: Results From the RELIEVE-HF Roll-In Cohort

Presenter: JoAnn Lindenfeld

February 02, 2022

Presentation THT 2022

Alleviant Medical Pivotal Study Overview and Next Steps

Presenter: James Udelson

February 02, 2022

Presentation THT 2022

Alleviant Medical Technology, Procedure and Clinical Data

Presenter: Colin Barker

February 02, 2022

Presentation THT 2022

Clinical Data and Landscape of Interatrial Shunting

Presenter: Peter Fail

February 02, 2022

Presentation THT 2022

Overview of HFpEF Disease State and Physiological Rationale for Atrial Shunting

Presenter: JoAnn Lindenfeld

February 02, 2022

Presentation THT 2022

Putting it into Perspective: Atrial Shunting in the Context of Current Therapies for HFpEF

Presenter: Scott Solomon

February 01, 2022

Presentation THT 2022

Subgroup Analyses of the REDUCE LAP-HF II Study of the Corvia Atrial Shunt

Presenter: Barry Borlaug

February 01, 2022

Presentation THT 2022

REDUCE LAP-HF II Randomized Study of the Corvia Atrial Shunt -- Primary Results

Presenter: Sanjiv Shah

February 01, 2022

Presentation THT 2022

Physiological Rationale and Devices for Interatrial Shunts

Presenter: JoAnn Lindenfeld

February 01, 2022

Presentation THT 2022

CON - Patients with Group 2 Pulmonary Hypertension are not candidates for interatrial shunts!

Presenter: Liviu Klein

February 01, 2022

Presentation THT 2022

PRO - Patients with Group 2 Pulmonary Hypertension are not candidates for interatrial shunts!

Presenter: Roham Zamanian

February 01, 2022

Presentation TCT 2021

Interatrial Shunts: Physiological Rationale and Hemodynamic Effects

Presenter: Daniel Burkhoff

November 06, 2021

Presentation TCT 2021

Implant-less Percutaneous Atrial Shunt-Catheter (PAS-C) System: InterShunt

Presenter: Harlee Sorkin

November 05, 2021

Presentation TCT 2021

Alleviant System: Implant-Free Interatrial Shunt Creation for Heart Failure

Presenter: Jacob Kriegel

November 05, 2021

Presentation TVT 2021

Interatrial Shunts for Heart Failure: Physiological and Device Concepts

Presenter: JoAnn Lindenfeld

July 22, 2021

Presentation TVT 2021

Implant-Free Intra-Atrial Shunt (Alleviant)

Presenter: Christopher Meduri

July 22, 2021

Presentation TCT 2020

Interatrial Shunting to Treat Heart Failure: Concept, Devices, and Data

Presenter: Daniel Burkhoff

October 17, 2020

Advertisement

What (Else) Have We Learned From REDUCE-LAP II?

Overview of the Interatrial Shunt Device Landscape: Conceptual Basis and Devices

The Alleviant No-Implant Interatrial Shunt for HF: The ALLEVIATE HF1 Trial Results

Interatrial Shunting in Chronic Heart Failure: Results From the RELIEVE-HF Roll-In Cohort

Alleviant Medical Pivotal Study Overview and Next Steps

Alleviant Medical Technology, Procedure and Clinical Data

Clinical Data and Landscape of Interatrial Shunting

Overview of HFpEF Disease State and Physiological Rationale for Atrial Shunting

Putting it into Perspective: Atrial Shunting in the Context of Current Therapies for HFpEF

Subgroup Analyses of the REDUCE LAP-HF II Study of the Corvia Atrial Shunt

REDUCE LAP-HF II Randomized Study of the Corvia Atrial Shunt -- Primary Results

Physiological Rationale and Devices for Interatrial Shunts

CON - Patients with Group 2 Pulmonary Hypertension are not candidates for interatrial shunts!

PRO - Patients with Group 2 Pulmonary Hypertension are not candidates for interatrial shunts!

Interatrial Shunts: Physiological Rationale and Hemodynamic Effects

Implant-less Percutaneous Atrial Shunt-Catheter (PAS-C) System: InterShunt

Alleviant System: Implant-Free Interatrial Shunt Creation for Heart Failure

Interatrial Shunts for Heart Failure: Physiological and Device Concepts

Implant-Free Intra-Atrial Shunt (Alleviant)

Interatrial Shunting to Treat Heart Failure: Concept, Devices, and Data

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content